These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16051967)

  • 1. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing cancer outcome: the role of LSUMC Minority-Based Clinical Community Oncology Program.
    Hayden J; Veith R; Thomas SM; Austin JP; Moore T
    J La State Med Soc; 1997 Apr; 149(4):131-3. PubMed ID: 9130816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecological analysis of the first generation of community clinical oncology programs.
    Schopler JH
    Health Serv Res; 1993 Apr; 28(1):69-95. PubMed ID: 8463110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizations and structures that facilitate community research.
    Coltman CA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
    Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities among clinical research investigators.
    Getz K; Faden L
    Am J Ther; 2008; 15(1):3-11. PubMed ID: 18223347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interorganizational exchanges as performance markers in a community cancer network.
    McKinney MM; Morrissey JP; Kaluzny AD
    Health Serv Res; 1993 Oct; 28(4):459-78. PubMed ID: 8407338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck cancer care at a community-based teaching hospital.
    Witt RL; Frelick RW
    Head Neck; 2005 Jul; 27(7):613-5. PubMed ID: 15825202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
    Joseph G; Dohan D
    Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
    Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
    Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
    Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruiting minority primary care practices into practice-based research.
    Hudson SV; Harris-Haywood S; Stange KC; Orzano AJ; Crabtree BF
    Med Care; 2006 Jul; 44(7):696-700. PubMed ID: 16799365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000).
    Oddone EZ; Olsen MK; Lindquist JH; Orr M; Horner R; Reda D; Lavori P; Johnson G; Collins J; Feussner JR
    Control Clin Trials; 2004 Aug; 25(4):378-87. PubMed ID: 15296812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
    Klabunde C; Kaluzny A; Ford L
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.